期刊文献+

野生型p53基因转移对血管内膜损伤后再狭窄的防治作用 被引量:2

Prevention and treatment of restenosis after endangium injury by using wild p53 genetransfer
下载PDF
导出
摘要 为防止血管成形术后管腔再狭窄,我们构建了介导野生型p53基因转移的复制缺陷型重组腺病毒(Ad-p53),将Ad-p53感染日本大耳兔球囊损伤后的髂动脉,并通过携带LacZ基因重组腺病毒感染观察基因转染效率。结果可见Ad-lacZ感染损伤后的动脉3天后血管内膜、中膜、外膜均有LacZ基因的阳性表达;Ad-p53感染损伤后的髂动脉2周后可见血管内膜增厚程度、内膜与中膜的比例明显减小,管腔狭窄程度明显减轻,p53蛋白大量表达,与对照组相比具有显著差异。证明野生型p53基因转移能明显抑制血管损伤后的内膜增殖,为野生型p53基因转移防治血管内膜损伤后再狭窄奠定了实验基础。 To prevent the process of restenosis after arterial injury,we constructed a replication defective adenovirus encoding wild type p53 gene by homologous recombination.In vivo studies,balloon injured rabbits's iliac segments were infected by Ad p53 and Ad lacz.The gene transfection efficiency was tested by x gal staining.The results showed that in vivo adenovirus vectors had high transferring efficiency by x gal staining.In the group treated by Ad p53,the thickening degree of initima and I/M greatly decreased,and p53 protein largely expressed after injuring 3 weeks.Our study demonstrated that wild type p53 genetransfer could greatly inhibit proliferation of arterial intima after balloon injury and this paper provided the experimental evidences for preventing arterial restenosis.
机构地区 哈尔滨医科大学
出处 《中国地方病学杂志》 CAS CSCD 1998年第6期362-364,共3页 Chinese Jouranl of Endemiology
基金 黑龙江省自然科学基金
关键词 野生型P53基因 血管损伤 腺病毒 基因疗法 Wild type p53 gene Vessel in Vessel injury Adenovirus Gene therapy
  • 相关文献

参考文献2

  • 1尹新华,中国地方病学杂志,1998年,1卷,1页
  • 2董薇,北京医科大学学报,1996年,26卷,增刊,140页

同被引文献15

  • 1马毅,陈细桃,朱晓峰,何晓顺,陈规划.大鼠异位心脏移植模型的术式探讨[J].中华实验外科杂志,2005,22(10):1238-1240. 被引量:15
  • 2王丽平,刘越,尹新华,贾智博,徐晶.腺病毒介导的外源基因转移至供心的实验研究[J].中国修复重建外科杂志,2007,21(4):416-419. 被引量:2
  • 3Hoffman FM.Outcomes and complications after heart transplantation:a review.J Cardiovasc Nurs.2005;20(5Suppl):S31-42.
  • 4George SJ,Angelini GD,Capogrossi MC,et al.Wild-type p53gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis.Gene Ther.2001;8(9):668-676.
  • 5The Ministry of Science and Technology of the People’s Republic of China.Guidance suggestion of caring laboratory animals.2006-09-30.中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006-09-30.
  • 6Sen L,Hong YS,Luo H,et al.Efficiency,efficacy,and adverse effects of adenovirus-vs.liposome-mediated gene therapy in cardiac allografts.Am J Physiol Heart Circ Physiol.2001;281(3):H1433-H1441.
  • 7Schneider MD,French BA.The advent of adenovirus.Gene therapy for cardiovascular disease.Circulation.1993;88(4Pt1):1937-1942.
  • 8Suzuki J,Isobe M,Morishita R,et al.Characteristics of chronic rejection in heart transplantion:important elements of pathogenesis and future treatments.Circ J.2010;74(2):233-239.
  • 9Kass M,Allan R,Haddad H.Diagnosis of graft coronary artery disease.Curr Opin Cardiol.2007;22(2):139-145.
  • 10Ascher E,Scheinman M,Hingorani A,et al.Effect of p53gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model.Ann Vasc Surg.2000;14(4):385-392.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部